Jie Xu

3.9k citations
117 papers · 2.6k indexed · 2 hit papers · h-index 27

Jie Xu

111 papers receiving 2.6k citations

Hit Papers

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion ...217202120262022202450100150200

Peers

Jie Xu
Comparison fields: 5 of 138
  • Aging 85
  • Business and International Management 67
  • Molecular Biology 1.4k
  • Genetics 554
  • Reproductive Medicine 116
Replace David A. Wright with:
David A. Wright United States
Mazhar Adli United States
Kunihiko Naito Japan
Takeshi Maruyama Japan
Wenjing Tao China
Yan Zhou China
Xiaohong Li United States
Jing Yang China
Jie Xu relative to David A. Wright United States David A. Wright's profile →
Citations per field
00.5×3.6×
David A. Wright · 1×
Citations per year

Countries citing papers authored by Jie Xu

Since Specialization
Citations

This map shows the geographic impact of Jie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Xu more than expected).

Fields of papers citing papers by Jie Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Xu. The network helps show where Jie Xu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jie Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jie Xu Line = papers co-authored together Jie Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20255
3 20241
4 20242
5 20242
6 20236
7
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillancebreakdown →
2023217
8 202314
9 20225
10 20225
11 202235
12 20222
13 202215
14 202112
15 202111
16 201810
17 201710
18 20155
19 201014
20 200628

About Jie Xu

Jie Xu is a scholar working on Aging, Business and International Management and Molecular Biology, having authored 117 papers that have together received 2.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (26 papers), Pluripotent Stem Cells Research (17 papers), Reproductive Biology and Fertility (16 papers), Animal Genetics and Reproduction (11 papers), Cystic Fibrosis Research Advances (9 papers), RNA Interference and Gene Delivery (4 papers), Mollusks and Parasites Studies (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). The work is most often cited by research in Aging (85 citations), Business and International Management (67 citations) and Molecular Biology (1.4k citations). Jie Xu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Jifeng Zhang, Y. Eugene Chen, Dongshan Yang, Jun Song, Tianqing Zhu, Jianglin Fan, Jinxue Ruan, Enqi Liu, Shuji Kitajima and Teruo Watanabe. Their work appears in journals such as Theriogenology, Reproduction Fertility and Development, Scientific Reports, Frontiers in Immunology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026